The bispecific antibody therapeutics pipeline has evolved significantly over the past few years


Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Market (4th Edition), 2020-2030.”



With various target combinations and novel mechanisms of action, bispecific antibodies are presently recognized as a potent class of targeted therapies, with the potential to be used as treatment options for a variety of disease indications. Several pipeline candidates have recently entered mid to late-stage (phase II and above) trials and are anticipated to enter the market over the next 5-10 years.


To order this 370+ page report, which features 90+ figures and 110+ tables, please visit this


The USD 6.9 billion financial opportunity (by 2030) within the bispecific antibody therapeutics market has been analyzed across the following segments:

  • Therapeutic Area
  • Autoimmune Disorders
  • Eye Disorders
  • Genetic Disorders
  • Hematological Malignancies
  • Infectious Diseases
  • Inflammatory Disorders
  • Skin Disorders


  • Mechanism of Action
  • Cytokines Retargeting / Neutralization
  • Dual Ligands Blocking
  • T-cell Retargeting / Activation
  • Others


  • Target Antigens
  • CD3 x CD19
  • CD30 x CD16A
  • Factor IXa x Factor X
  • IL-1α x IL-1β
  • IL-13 x IL-4
  • IL-17A x Albumin
  • IL-17A x IL-17F
  • Psl x PcrV
  • VEGF-A x ANG2
  • Others


  • Antibody Formats
  • Asymmetric
  • Fragments
  • Symmetric
  • Others


  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific


The Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • Amgen
  • Ablynx
  • AbbVie
  • Affibody
  • Affimed
  • Alphamab
  • AstraZeneca
  • Avillion
  • Chugai Pharmaceuticals
  • Eddingpharm
  • GSK
  • Merck
  • Merus
  • Roche
  • Regeneron Pharmaceuticals
  • Taisho Pharmaceuticals
  • Zymeworks


Table of Contents


  1. Preface

    2. Executive Summary

  2. Introduction
  3. Market Overview
  4. Bispecific Antibody Therapeutics: Technology Platforms
  5. Drug Profiles
  6. Key Insights
  7. Benchmark Analysis: Big Pharma Players
  8. Partnerships and Collaborations
  9. Contract Services for Bispecific Antibody Therapeutics
  10. Clinical Trial Analysis
  11. Case Study: Regulatory Guidelines for Bispecific Antibodies
  12. Case Study: Promotional / Marketing Strategies
  13. SWOT Analysis


  1. Market Forecast and Opportunity Analysis


  1. Concluding Remarks


  1. Executive Insights


  1. Appendix 1: Tabulated Data


  1. Appendix 2: List of Companies and Organizations



For more information please click on the following link:


Other Recent Offerings

  1. Global Preventive Vaccines Market, 2020-2030
  2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030
  3. Antibody Contract Manufacturing Market, 2020-2030




About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]


Contact Information

Roots Analysis Private Limited

Ben Johnson

+1 (415) 800 3415

[email protected]

Facebook –

LinkedIn –

Twitter –

Medium –

Pinterest –

Quora –

Back to top button